Decision-theoretic designs for dose-finding clinical trials with multiple outcomes.
A decision-theoretic framework is proposed for designing sequential dose-finding trials with multiple outcomes. The optimal strategy is solvable theoretically via backward induction. However, for dose-finding studies involving k doses, the computational complexity is the same as the bandit problem with k-dependent arms, which is computationally prohibitive. We therefore provide two computationally compromised strategies, which is of practical interest as the computational complexity is greatly reduced: one is closely related to the continual reassessment method (CRM), and the other improves CRM and approximates to the optimal strategy better. In particular, we present the framework for phase I/II trials with multiple outcomes. Applications to a pediatric HIV trial and a cancer chemotherapy trial are given to illustrate the proposed approach. Simulation results for the two trials show that the computationally compromised strategy can perform well and appear to be ethical for allocating patients. The proposed framework can provide better approximation to the optimal strategy if more extensive computing is available.
Fan
Shenghua K
SK
Department of Statistics and Applied Probability, National University of Singapore, 6 Science Drive 2, Singapore 117546, Singapore. kelly_shfan@yahoo.com
Wang
You-Gan
YG
D000465:Algorithms; D019380:Anti-HIV Agents / Q000494:pharmacology; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage / Q000009:adverse effects; D002675:Child, Preschool; D017321:Clinical Trials, Phase I as Topic / Q000379:methods*; D003198:Computer Simulation; D003662:Decision Theory; D064420:Drug-Related Side Effects and Adverse Reactions; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage / Q000009:adverse effects; D004364:Pharmaceutical Preparations / Q000008:administration & dosage*; D012509:Sarcoma / Q000188:drug therapy
D019380:Anti-HIV Agents; D018906:Antineoplastic Agents, Alkylating; D004364:Pharmaceutical Preparations; D007069:Ifosfamide